Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis

医学 多发性硬化 累积发病率 入射(几何) 危险系数 麦当劳标准 队列 病变 临床试验 内科学 比例危险模型 降级 队列研究 芬戈莫德 年轻人 回顾性队列研究 随机对照试验 疾病严重程度 儿科 不利影响 磁共振成像 外科 无症状的 累积剂量 置信区间 前瞻性队列研究 疾病
作者
Cyrus Daruwalla,Courtney Kremler,Francesco Patti,Serkan Ozakbas,Cavit Boz,Lechner-Scott Js,Andrea Surcinelli,Matteo Foschi,Khoury Sj,H Butzkueven,Anneke van der Walt,Zuzana Rous,Mario Habek,J E Meca-Lallana,Gabriel Valero Lopez,Raed Alroughani,Yolanda Blanco,Guy Laureys,Olga Skibina,Katherine Buzzard
出处
期刊:Brain [Oxford University Press]
标识
DOI:10.1093/brain/awag252
摘要

Clinically silent MRI lesions occur frequently in people with relapsing-remitting multiple sclerosis (RRMS) despite disease modifying therapy (DMT). Guidelines only routinely recommend DMT escalation after multiple silent lesions, and adherence is variable. We explored outcomes and the effect of treatment escalation following single and multiple on-treatment silent lesions. This cohort study and emulated target trial used MSBase registry data from 99 clinics in 26 countries between 2007 and 2025. Clinically stable participants receiving any DMT for RRMS with silent lesions versus without silent lesions were compared. Among participants with silent lesions while taking platform or moderate-efficacy DMTs, outcomes following treatment escalation within 6 months versus no treatment escalation (unless a post-MRI clinical event occurred) were compared. The primary outcome was an MS relapse, and the secondary outcome was 6-month confirmed disability worsening. A total of 10,232 participants met inclusion criteria (71.7% female, mean age 41 [SD 11]). The 2-year cumulative incidence of relapse was 27.8% (95% CI: 25.7%-29.9%) in participants with silent lesions versus 14.3% (95% CI: 13.5%-15.2%) without (adjusted hazard ratio [aHR] 1.76 [95% CI: 1.57-1.97]). The 2-year cumulative incidence of disability worsening was 13.8% (95% CI: 12.2%-15.5%) in participants with silent lesions versus 11.4% (95% CI: 10.7%-12.2%) without (aHR 1.38 [95% CI: 1.18-1.62]). Rates of relapse and disability worsening were higher following single and multiple silent lesions versus no silent lesions. The emulated trial included 2,264 participants with ≥1 silent lesion on platform or moderate efficacy DMTs, 286 of whom escalated DMT within 6 months following silent lesions. The 4-year cumulative incidence of relapse was lower following treatment escalation (16.8% [95% CI: 12.4%-23.4%]) versus continuation (38.9% [95% CI: 35.8%-42.1%]), aHR 0.34 (95% CI: 0.23-0.47), with similar aHRs following single and multiple silent lesions. The 4-year cumulative incidence of disability worsening was similar following treatment escalation (16.0% [95% CI: 10.8%-22.2%]) versus continuation (17.7% [95% CI: 15.3%-20.1%]), aHR 0.89 (95% CI: 0.56-1.33). People with RRMS with single or multiple on-treatment silent MRI lesions have higher subsequent risks of relapse and disability worsening than people without silent lesions. DMT escalation mitigates the relapse risk, though disability worsening continues at a similar rate over 4 years. Contrary to guidelines, DMT escalation should be considered after single or multiple silent lesions.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
YUE完成签到,获得积分10
刚刚
务实映之完成签到,获得积分10
刚刚
刚刚
摸鱼大王发布了新的文献求助10
刚刚
刚刚
小子的小子完成签到,获得积分10
刚刚
Ava的应助被鳗鱼不二采纳,获得10
1秒前
1秒前
Akim的应助被只想发SCI采纳,获得10
1秒前
gl发布了新的文献求助10
1秒前
kk完成签到,获得积分10
1秒前
sherry完成签到,获得积分20
1秒前
爆米花的应助被请较老嘚采纳,获得10
1秒前
1秒前
漂亮书萱发布了新的文献求助30
1秒前
思源的应助被最爱炸里脊采纳,获得10
2秒前
泛化发布了新的文献求助30
2秒前
2秒前
LiZhao完成签到,获得积分10
2秒前
俊俊完成签到,获得积分10
2秒前
小汪完成签到,获得积分10
3秒前
Ava的应助被芒果采纳,获得10
3秒前
酷酷柚子发布了新的文献求助10
3秒前
yu发布了新的文献求助10
4秒前
4秒前
阿吟发布了新的文献求助10
4秒前
小二郎的应助被咿呀学语采纳,获得10
4秒前
坦率的匪发布了新的文献求助300
4秒前
小黑完成签到,获得积分10
4秒前
111发布了新的文献求助10
5秒前
howay发布了新的文献求助10
5秒前
泥猴桃完成签到,获得积分10
5秒前
helly完成签到,获得积分10
5秒前
6秒前
afd完成签到,获得积分10
6秒前
刘昊然的老婆完成签到 ,获得积分10
6秒前
优雅盼海发布了新的文献求助10
6秒前
演化的蛙鱼完成签到,获得积分10
6秒前
6秒前
晚心发布了新的文献求助10
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181072
求助须知:如何正确求助?哪些是违规求助? 9571092
关于积分的说明 21816478
捐赠科研通 7777477
什么是DOI,文献DOI怎么找? 3433418
关于科研通互助平台的介绍 2557638
邀请新用户注册赠送积分活动 2479460